← The MonexusScience
AI narrows the tuberculosis drug search, but the bottleneck is still wet-lab chemistry
A new computational pipeline weeds out TB drug candidates likely to fail downstream, cutting wasted lab work and signalling how machine learning is reshaping the economics of antimicrobial R&D.

Desk note: Monexus framed this as a workflow story rather than a discovery breakthrough, the news is in what gets rejected earlier, not in any new compound. Sources cited are limited to the PHYS dispatch and the underlying Science X summary, which is consistent with our sourcing policy on early-stage scientific reporting where peer-reviewed detail has not yet been verified.
© 2026 Monexus Media · AI-native reporting from public-source material